Skip to main content
INBS
NASDAQ Industrial Applications And Services

INBS Registers 6.2M Shares for Resale from $5M Private Placement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$2.05
Mkt Cap
$6.206M
52W Low
$1.52
52W High
$24.9
52W Position info
35% above low
Off High info
92% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

INBS sits 35% above its 52-week low of $1.52 on light trading volume (0.2× avg).

Summary

Intelligent Bio Solutions filed an S-3 to register 6.2 million shares for resale by investors from its recent $5 million private placement, making the warrant overhang tradable and revealing new warrant and placement agent terms.


Key Events · Financing and Capital Events · INBS

  • 6.2M Shares Registered for Resale

    S-3 registers 6,211,809 shares underlying Series M pre-funded warrants, Series N-1 and N-2 warrants, and placement agent warrants from the September Private Placement.

  • Warrant Exercise Prices Disclosed

    Series N-1 and N-2 warrants are exercisable at $2.33 per share; Series M pre-funded warrants at $0.01; placement agent warrants at $3.06875.

  • Placement Agent Compensation

    Ladenburg received 8% cash fee, 1% management fee, 9% fee on warrant exercises, 101,832 warrants, and up to $145,000 expense reimbursement.

  • Stockholder Approval Required

    Series N-2 warrants require stockholder approval, with a meeting deadline of December 31, 2026.


Analysis · INBS · Industrial Applications And Services

This S-3 registers 6,211,809 shares for resale by Alyeska Master Fund and Ladenburg affiliates, the shares underlying warrants issued in the September Private Placement that closed September 2, 2026. The registration makes the overhang tradable — a key step that could pressure the stock as the investor and placement agent gain liquidity. The filing also reveals new terms: Series N-1 and N-2 warrants carry a $2.33 exercise price, the placement agent received 101,832 warrants at $3.06875, and stockholder approval for the Series N-2 warrants is required by December 31, 2026. With only 3,316,803 shares outstanding, the 6.2 million registered shares represent a substantial potential increase in the float if exercised and sold.

How filings like this one have moved

In the 30 days to Oct 17, 2026, 29.7% of the 1528 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INBS was trading at $2.05 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.2M. The 52-week trading range was $1.52 to $24.90. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INBS - Latest Insights

INBS
Sep 23, 2026, 5:27 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $1.78
Real-time Price: $1.52 info
Change: -$0.2607 (-15%) info
Market Cap: $4.975M info
INBS
Sep 09, 2026, 8:50 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.24
Real-time Price: $1.52 info
Change: -$0.7207 (-32%) info
Market Cap: $4.975M info
INBS
Sep 09, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.24
Real-time Price: $1.52 info
Change: -$0.7207 (-32%) info
Market Cap: $4.975M info
INBS
Sep 02, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.48
Real-time Price: $1.52 info
Change: -$0.9607 (-39%) info
Market Cap: $4.975M info
INBS
Sep 01, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.63
Real-time Price: $1.52 info
Change: -$1.11 (-42%) info
Market Cap: $4.975M info